Methylphenidate extended release - Highland Therapeutics
At a glance
- Drug Originator Highland Therapeutics
- Drug Licenced by Ironshore Pharmaceuticals (America) Inc; Knight Therapeutics
- Drug Class Behavioural disorder therapies; Neuroprotectants; Nootropics; Phenylacetates; Piperidines; Sleep disorder therapies; Small molecules
- Mechanism of Action Adrenergic uptake inhibitors; Central nervous system stimulants; Dopamine uptake inhibitors; Monoamine oxidase inhibitors
- USA Patent Applicants IRONSHORE PHARMS
- USA Patents 22
- NDAs 1
- International Patents 40
- Patent Applications 3,740
Disclaimer